Abstracts

LIPIDOME ALTERATIONS WITH EXERCISE AMONG PEOPLE WITH AND WITHOUT HIV

An increasing burden of age-related comorbidities and impairment of physical function in aging people with HIV (PWH) can be improved, in part, through exercise interventions. The effect of exercise and HIV serostatus on the mechanisms underlying these improvements, such as changes in lipidome composition, is not known.  Sedentary adults (50-75 years old) with (N=24) or…

FROM GUT TO BLOOD: REDISTRIBUTION OF ZONULIN IN HIV+ PATIENTS

Gastro-intestinal mucosal damage in HIV infection causes microbial translocation and immune activation, which in turn results in non-infectious comorbidities. Combined antiretroviral therapy (cART) restores this intestinal damage only partially. Various biomarkers of the epithelial barrier have been reported but some are not considered specific while others are impacted by cART. Zonulin is a modulator for…

IMPACT OF INTRAVENOUS HEROIN AND HIV ON GUT INTEGRITY AND IMMUNE ACTIVATION

Altered gut integrity and translocation of microbial products appear to be central in HIV-related immune activation. Opioid use may promote similar changes in gut permeability potentially augmenting immune activation in HIV-infected opioid users. Injection as a route administration may also heighten inflammation. Excess immune activation may increase risk of co-morbid metabolic conditions and contribute to…

GUT BARRIER PROTECTANT INTESTINAL ALKALINE PHOSPHATASE IS REDUCED IN PEOPLE WITH HIV

Gastrointestinal (GI) microbial translocation in people with HIV (PWH) is associated with systemic immune activation and inflammation. The intestinal brush border enzyme intestinal alkaline phosphatase (IAP) is important for maintaining healthy GI barrier function. IAP promotes intestinal homeostasis by regulating the pH of the gut luminal surface via bicarbonate secretion and by detoxifying lipopolysaccharides (LPS).…

LIPID ABNORMALITIES MAY CONTRIBUTE TO ALTERED MACROPHAGE PHENOTYPE IN PEOPLE WITH HIV

HIV infection and antiretroviral therapy (ART) are associated with dyslipidemia and increased cardiovascular disease (CVD) risk. Macrophages accumulate in arterial walls and produce factors that contribute to vascular inflammation. The relationships among lipids and macrophage phenotype in people with HIV (PWH) are unclear. Coronary artery calcification (CAC) in people with (n=40) and without (n=15) HIV…

CELLULAR STRESS BIOMARKERS ARE ASSOCIATED WITH MARKERS OF MICROBIAL TRANSLOCATION

Microbes and microbe components that translocate from the lumen of the GI tract can directly stimulate the immune system and contribute to inflammation. Given that microbial translocation occurs in many chronic diseases, defining reliable biomarkers that reflect microbial translocation is essential for proper inflammatory diagnoses. Host proteins produced in response to microbial antigenic stimulation are often used…

ANTIINFLAMMATORY EFFECT OF METFORMIN ON MICROBIOTA IN NONDIABETIC PEOPLE WITH HIV

People living with HIV (PLWH) on antiretroviral therapy (ART) remain at increased risks of inflammatory comorbidities. Metformin, an anti-diabetic drug with anti-aging effect, was shown to decrease inflammation by improving glucose metabolism and changing gut microbiota composition in diabetic people. Herein, we report results from the LILAC (CIHR/CTN PT027) clinical trial evaluating the effect of…